Muc5b is required for airway defence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Respiratory surfaces are exposed to billions of particulates and pathogens daily. A protective mucus barrier traps and eliminates them through mucociliary clearance (MCC). However, excessive mucus contributes to transient respiratory infections and to the pathogenesis of numerous respiratory diseases. MUC5AC and MUC5B are evolutionarily conserved genes that encode structurally related mucin glycoproteins, the principal macromolecules in airway mucus. Genetic variants are linked to diverse lung diseases, but specific roles for MUC5AC and MUC5B in MCC, and the lasting effects of their inhibition, are unknown. Here we show that mouse Muc5b (but not Muc5ac) is required for MCC, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable. Muc5b deficiency caused materials to accumulate in upper and lower airways. This defect led to chronic infection by multiple bacterial species, including Staphylococcus aureus, and to inflammation that failed to resolve normally. Apoptotic macrophages accumulated, phagocytosis was impaired, and interleukin-23 (IL-23) production was reduced in Muc5b(-/-) mice. By contrast, in mice that transgenically overexpress Muc5b, macrophage functions improved. Existing dogma defines mucous phenotypes in asthma and chronic obstructive pulmonary disease (COPD) as driven by increased MUC5AC, with MUC5B levels either unaffected or increased in expectorated sputum. However, in many patients, MUC5B production at airway surfaces decreases by as much as 90%. By distinguishing a specific role for Muc5b in MCC, and by determining its impact on bacterial infections and inflammation in mice, our results provide a refined framework for designing targeted therapies to control mucin secretion and restore MCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as evidenced by the decrease in antibacterial cytokines and the presence of phagocytosis-impaired macrophages in the lungs of mucin-deficient mice133.”
From The microbiota of the respiratory tract: gatekeeper to respiratory health (2017) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Webb, A. K. (2006) · Cited by 4,369
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Self-citationAirway Mucus Function and Dysfunction
Fahy, J. V., & Dickey, B. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0910061 · Cited by 1,722
Self-citationAn efficient recombination system for chromosome engineering in Escherichia coli
Yu, D., Ellis, H. M., Lee, E.-C., Jenkins, N. A., Copeland, N. G., & Court, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127597 · Cited by 1,688
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Self-citation
Cited by
Items 101–200 of 767
The impact of lung microbiota dysbiosis on inflammation
Yang, D., Xing, Y., Song, X., & Qian, Y. (2019) · Immunology · doi:10.1111/imm.13139 · Cited by 108
An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence
Morin, C. D., Déziel, É., Gauthier, J., Lévesque, R. C., & Lau, G. W. (2021) · Virulence · doi:10.1080/21505594.2021.1926408 · Cited by 111
“A major pathophysiological consequence of pyocyanin lies in its ability to cause excessive expression of mucin glycoproteins MUC5AC and MUC5B [62,202,205].”
BackgroundInfluentialDesmoplakin variants are associated with idiopathic pulmonary fibrosis
Mathai, S. K., Pedersen, B. S., Smith, K., Russell, P., Schwarz, M. I., Brown, K. K., Steele, M. P., Loyd, J. E., Crapo, J. D., Silverman, E. K., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1863oc · Cited by 89
Self-citationSwamynathan, S. K., & Wells, A. H. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.11.005 · Cited by 92
Bovine respiratory microbiota of feedlot cattle and its association with disease
Chai, J., Capik, S. F., Kegley, B., Richeson, J. T., Powell, J. G., & Zhao, J. (2022) · Veterinary Research · doi:10.1186/s13567-021-01020-x · Cited by 87
“In healthy cattle, a mucosal layer covers the respiratory tract and provides immune and physical protection for maintaining homeostasis under the interactions of the host, microbiotas and the external environments [15, 37, 108, 109] (Figure 2).”
BackgroundGhosh, A., Boucher, R. C., & Tarran, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1946-7 · Cited by 103
“Mucin knockout mice exist (MUC5b) and exhibit increased susceptibility to infection [64], but the effects of tobacco exposure on these mice have not been established.”
BackgroundSelf-citationEndogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis
Kiwamoto, T., Katoh, T., Evans, C. M., Janssen, W. J., Brummet, M. E., Hudson, S. A., Zhu, Z., Tiemeyer, M., & Bochner, B. S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.027 · Cited by 100
“Muc5b and wild-type control animals were started on antibiotic diets 1 week before challenge to reduce the effects of bacterial infection in the airways of Muc5b-deficient mice.(18) All animal procedures were approved by the Johns Hopkins University and the University of Colorado School of Medicine Institutional Anima…”
Self-citationRecent advances in understanding idiopathic pulmonary fibrosis
Daccord, C., & Maher, T. M. (2016) · F1000Research · doi:10.12688/f1000research.8209.1 · Cited by 87
ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites
Campbell, L., Hepworth, M. R., Whittingham‐Dowd, J., Thompson, S., Bancroft, A. J., Hayes, K. S., Shaw, T. N., Dickey, B. F., Flamar, A.-L., Artis, D., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180610 · Cited by 94
“In mice, Muc5b is required for maintaining immune homeostasis in the lungs (Roy et al., 2014), whereas Muc5ac is up-regulated in allergic inflammation (Evans et al.”
BackgroundMethodSelf-citationThe Human Respiratory Microbiome: Current Understandings and Future Directions
Zhao, L., Luo, J., Ali, M. K., Spiekerkoetter, E. F., & Nicolls, M. R. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0208tr · Cited by 102
“To sum up, mucus infection, dysfunction, and impaired mucus clearance are common features of airway diseases (112), and maintaining a healthy mucus layer is crucial for a better life.”
BackgroundAirway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
Singanayagam, A., Footitt, J., Marczynski, M., Radicioni, G., Cross, M. T., Finney, L., Trujillo‐Torralbo, M., Calderazzo, M. A., Zhu, J., Aniscenko, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci120901 · Cited by 95
“Animal studies have identified critical roles for MUC5AC and MUC5B in anti-viral and antibacterial host-defense (8, 9) suggesting that therapies targeting mucin production may compromise the protective role for mucins during exacerbations.”
Self-citationWelch, C. B., Ryman, V. E., Pringle, T. D., & Lourenco, J. M. (2022) · Microorganisms · doi:10.3390/microorganisms10071391 · Cited by 113
Genetics and Early Detection in Idiopathic Pulmonary Fibrosis
Putman, R. K., Rosas, I. O., & Hunninghake, G. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2219pp · Cited by 91
Hughes, G. W., Ridley, C., Collins, R., Roseman, A., Ford, R., & Thornton, D. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-53768-0 · Cited by 83
Self-citationDuclos, G. E., TEIXEIRA, V. H., Autissier, P., Gesthalter, Y. B., Reinders-Luinge, M., Terrano, R., Dumas, Y. M., Liu, G., Mazzilli, S. A., Brandsma, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw3413 · Cited by 92
Emerging role of immune cells as drivers of pulmonary fibrosis
Mutsaers, S. E., Miles, T., Prêle, C. M., & Hoyne, G. F. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108562 · Cited by 96
Lakshmanan, I., Rachagani, S., Hauke, R. J., Krishn, S. R., Paknikar, S., Seshacharyulu, P., Karmakar, S., Nimmakayala, R. K., Kaushik, G., Johansson, S. L., et al. (2016) · Oncogene · doi:10.1038/onc.2015.478 · Cited by 94
The effect of physical exercise on salivary secretion of MUC5B, amylase and lysozyme
Ligtenberg, A. J. M., Brand, H. S., van den Keijbus, P. A. M., & Veerman, E. C. I. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.07.012 · Cited by 98
Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions
Janssen, W. J., Stefanski, A. L., Bochner, B. S., & Evans, C. M. (2016) · European Respiratory Journal · doi:10.1183/13993003.00120-2015 · Cited by 92
Self-citationPulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Self-citationBowman, W. S., Echt, G. A., & Oldham, J. M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.680997 · Cited by 77
“The variant with strongest effect is a polymorphism in the promoter region of MUC5B, which encodes a mucin producing gene critical for airway host defense (106).”
BackgroundHey, J., Paulsen, M., Tóth, R., Weichenhan, D., Butz, S., Schatterny, J., Liebers, R., Lutsik, P., Plass, C., & Mall, M. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26777-9 · Cited by 77
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Giacomelli, C., Piccarducci, R., Marchetti, L., Romei, C., & Martini, C. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114812 · Cited by 84
Physiological and immunological barriers in the lung
Kageyama, T., Ito, T. K., Tanaka, S., & Nakajima, H. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01003-y · Cited by 101
“Furthermore, the absence of MUC5B may result in impaired mucociliary clearance by persistent inflammation [30].”
BackgroundRole of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Paudel, K. R., Dharwal, V., Patel, V. K., Galvão, I., Wadhwa, R., Malyla, V., Shen, S., Budden, K. F., Hansbro, N. G., Vaughan, A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00554 · Cited by 84
Self-citationInvernizzi, R., Barnett, J. L., Rawal, B., Nair, A., Ghai, P., Kingston, S., Chua, F., Wu, Z., Wells, A. U., Renzoni, E., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01519-2019 · Cited by 75
Epithelial Barrier Function and Immunity in Asthma
Davies, D. E. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201407-304aw · Cited by 74
Zhou, J.-S., Zhao, Y., Zhou, H.-B., Wang, Y., Wu, Y.-F., Li, Z.-Y., Xuan, N.-X., Zhang, C., Hua, W., Ying, S.-M., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00418.2015 · Cited by 72
“In particular, MUC5B is constitutively expressed in the airway which is critically involved in the host defense (35), whereas MUC5AC is highly inducible especially in pathological conditions (15, 41).”
BackgroundYuan, S., Liu, Q., Hu, Z., Zhou, Z., Wang, G., Li, C., Xie, W., Meng, G., Xiang, Y., Wu, N., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0472-6 · Cited by 71
Spagnolo, P., Molyneaux, P. L., Bernardinello, N., Cocconcelli, E., Biondini, D., Fracasso, F., Tinè, M., Saetta, M. P., Maher, T. M., & Balestro, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225618 · Cited by 77
“In addition, mutations in the MUC5B gene, which encodes a mucin required for normal macrophage function and effective muco-ciliary clearance of bacteria in mice [7], is associated with an increased risk of developing both familiar and sporadic IPF [8], suggesting that bacteria may act as a cofactor in fibrosis initiat…”
BackgroundThe Japanese respiratory society guidelines for the management of cough and sputum (digest edition)
Mukae, H., Kaneko, T., Obase, Y., Shinkai, M., Katsunuma, T., Takeyama, K., Terada, J., Niimi, A., Matsuse, H., Yatera, K., et al. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.01.007 · Cited by 82
Oxidative and endoplasmic reticulum stress in respiratory disease
Chen, A. C. –., Burr, L. D., & McGuckin, M. A. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1019 · Cited by 74
“When the mucus barrier has increased viscosity making it resistant to mucociliary clearance, or when the barrier is deficient or depleted, the risk of opportunistic microbial infection is increased.(24) Mucins, primarily MUC5B, are tonically secreted by”
BackgroundTargeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers
Garudadri, S., & Woodruff, P. G. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-533mg · Cited by 76
Self-citationDisulfide disruption reverses mucus dysfunction in allergic airway disease
Morgan, L. E., Jaramillo, A. M., Shenoy, S., Raclawska, D. S., Emezienna, N. A., Richardson, V. L., Hara, N., Harder, A. Q., Needell, J. C., Hennessy, C. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20499-0 · Cited by 91
Self-citationZhao, Y., Jamaluddin, M., Zhang, Y., Sun, H., Ivanciuc, T., Garofalo, R. P., & Brasier, A. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601291 · Cited by 71
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
Kato, T., Asakura, T., Edwards, C. E., Dang, H., Mikami, Y., Okuda, K., Chen, G., Sun, L., Gilmore, R. C., Hawkins, P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202111-2606oc · Cited by 68
Self-citationEnvironmental Causes of Idiopathic Pulmonary Fibrosis
Gandhi, S. A., Tonelli, R., Murray, M., Samarelli, A. V., & Spagnolo, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216481 · Cited by 76
“MUC5B plays an important role in the mucociliary clearance that is essential for removing inhaled debris and pathogens in lung homeostasis [11,12].”
BackgroundChen, G., Ribeiro, C. M. P., Sun, L. V., Okuda, K., Kato, T., Gilmore, R. C., Martino, M. B., Dang, H., Abzhanova, A., Lin, J. M., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1972oc · Cited by 82
Self-citationPathophysiology of Chronic Bronchial Infection in Bronchiectasis
Solarat, B., Perea, L., Faner, R., de la Rosa, D., Martínez‐García, M. Á., & Sibila, O. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.09.004 · Cited by 71
MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium
Song, D., Iverson, E., Kaler, L., Boboltz, A., Scull, M. A., & Duncan, G. A. (2022) · Science Advances · doi:10.1126/sciadv.abq5049 · Cited by 73
Reynolds, C., Fabiola Del Greco, M., Allen, R. J., Flores, C., Jenkins, G. R., Maher, T. M., Molyneaux, P. L., Noth, I., Oldham, J. M., Wain, L. V., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.01585-2022 · Cited by 76
“In evolutionary terms, it is a highly conserved airway mucin that plays a key role in antimicrobial host defence [31], and has been shown to reduce mucosal bacterial load and to promote mucosal microbial diversity [32].”
Strategies for measuring airway mucus and mucins
Atanasova, K. R., & Reznikov, L. R. (2019) · Respiratory Research · doi:10.1186/s12931-019-1239-z · Cited by 86
Current models of pulmonary fibrosis for future drug discovery efforts
Yanagihara, T., Chong, S. G., Vierhout, M., Hirota, J. A., Ask, K., & Kolb, M. R. J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1755252 · Cited by 73
“MUC5B encodes mucin 5B, a glycoprotein required for airway clearance and innate immune response to bacteria [54].”
BackgroundMicrobiota and Immunity during Respiratory Infections: Lung and Gut Affair
Marrella, V., Nicchiotti, F., & Cassani, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074051 · Cited by 79
Mohammed, A. K., Alghetaa, H., Zhou, J., Chatterjee, S., Nagarkatti, P. S., & Nagarkatti, M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15226 · Cited by 69
“Mucin is one of the most important components of mucus and plays a crucial role in the defence against bacterial pneumonia, maintenance of the integrity of lung tissue and prevention of vascular leak (Johansson et al., 2011; Roy et al., 2014).”
BackgroundArchaic Hominin Introgression in Africa Contributes to Functional Salivary MUC7 Genetic Variation
Xu, D., Pavlidis, P., Taskent, R. O., Alachiotis, N., Flanagan, C., DeGiorgio, M., Blekhman, R., Ruhl, S., & Gokcumen, O. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx206 · Cited by 62
“Earlier studies have claimed that the copy number variation of MUC7 PTS-repeats in humans is related to upperrespiratory infections (Kirkbride et al. 2001) as it was shown for the larger, functionally but not evolutionarily related mucin in saliva, MUC5B (Roy et al. 2014).”
BackgroundAttached stratified mucus separates bacteria from the epithelial cells in COPD lungs
Fernández-Blanco, J. A., Arike, L., Ermund, A., Fakih, D., Rodríguez-Piñeiro, A. M., Martínez‐Abad, B., Skansebo, E., Jackson, S., Root, J., Singh, D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120994 · Cited by 66
Self-citationEmerging Concepts and Therapies for Mucoobstructive Lung Disease
Mall, M. A., Danahay, H. L., & Boucher, R. C. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201806-368aw · Cited by 66
Self-citationJaramillo, A. M., Azzegagh, Z., Tuvim, M. J., & Dickey, B. F. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201806-371aw · Cited by 62
Self-citationInnate immune responses in pneumonia
Korkmaz, F. T., & Traber, K. E. (2023) · Pneumonia · doi:10.1186/s41479-023-00106-8 · Cited by 94
“MUC5B is especially critical for homeostatic regulation of mucociliary clearance, the lack of which leads to chronic infection and a reduction in macrophage function and interleukin-23 (IL-23) production [8].”
BackgroundRole of mucins in lung homeostasis: regulated expression and biosynthesis in health and disease
Symmes, B. A., Stefanski, A. L., Magin, C. M., & Evans, C. M. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170455 · Cited by 72
“The consensus favoring a homeostatic role for MUC5B/Muc5b expression at baseline stems from findings that it is essential in the mouse respiratory tract to facilitate MCC and thus prevent infection [45,46].”
BackgroundSelf-citationOld dogs—new tricks: immunoregulatory properties of C3 and C5 cleavage fragments
Verschoor, A., Karsten, C. M., Broadley, S. P., Laumonnier, Y., & Köhl, J. (2016) · Immunological Reviews · doi:10.1111/imr.12473 · Cited by 61
Montgomery, M. T., Sajuthi, S. P., Cho, S., Everman, J. L., Rios, C. L., Goldfarbmuren, K. C., Jackson, N. D., Saef, B. A., Cromie, M. M., Eng, C. S., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0454oc · Cited by 68
Idiopathische Lungenfibrose – Epidemiologie, Ursachen und klinischer Verlauf
Schäfer, S. C., Funke-Chambour, M., & Berezowska, S. (2020) · Der Pathologe · doi:10.1007/s00292-019-00747-x · Cited by 63
Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease
McKelvey, M. C., Brown, R. R., Ryan, S. M., Mall, M. A., Weldon, S., & Taggart, C. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095018 · Cited by 62
“Importantly MUC5B is required for MCC and therefore its degradation could in fact hinder airway clearance [58].”
BackgroundInfluentialAirway Epithelial Innate Immunity
Johnston, S. L., Goldblatt, D. L., Evans, S. E., Tuvim, M. J., & Dickey, B. F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.749077 · Cited by 71
Self-citationImmune Response to Respiratory Viral Infections
Gambadauro, A., Galletta, F., Pomi, A. L., Manti, S., & Piedimonte, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116178 · Cited by 67
“Mucins (MUC5B and MUC5AC), high-molecular-weight glycoproteins, interact with allergens and pathogens that can be trapped within the mucus and easily removed by the movement of cilia of the epithelial cells [26,27].”
BackgroundReduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin
Grubb, B. R., Livraghi-Butrico, A., Rogers, T. D., Yin, W., Button, B. M., & Ostrowski, L. E. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00015.2016 · Cited by 59
“We have recently shown that, in mice, Muc5b, but not Muc5ac, is necessary for normal airway MCC (35).”
BackgroundMethodInfluentialSelf-citationNie, M., Bal, M., Yang, Z., Liu, J., Rivera, C., Wenzel, A., Beck, B. B., Sakhaee, K., Marciano, D. K., & Wolf, M. T. F. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101100 · Cited by 56
Saku, A., Hirose, K., Ito, T. K., Iwata, A., Sato, T., Kaji, H., Tamachi, T., Suto, A., Goto, Y., Domino, S. E., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.05.010 · Cited by 60
The airway epithelium in asthma
Bonser, L. R., & Erle, D. J. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.05.001 · Cited by 68
Mucins as a New Frontier in Pulmonary Fibrosis
Ballester, B., Milara, J., & Cortijo, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091447 · Cited by 67
“is required for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in the lungs [86].”
BackgroundZhu, Y., Abdullah, L. H., Doyle, S. P., Nguyen, K., Ribeiro, C. M. P., Vásquez, P. A., Forest, M. G., Lethem, M. I., Dickey, B. F., & Davis, C. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127267 · Cited by 54
Self-citationKrishack, P. A., Louviere, T. J., Decker, T. S., Kuzel, T. G., Greenberg, J. A., Camacho, D. F., Hrusch, C. L., Sperling, A. I., & Verhoef, P. A. (2019) · JCI Insight · doi:10.1172/jci.insight.124168 · Cited by 62
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
Michalski, J. E., & Schwartz, D. A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s280958 · Cited by 67
Self-citationAbnormal Airway Mucus Secretion Induced by Virus Infection
Li, Y., & Tang, X. X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701443 · Cited by 65
“The changes in mucus properties are related to the increased mucin expression during IV infection (68, 69, 75).”
BackgroundMUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model
Huang, X., Guan, W., Xiang, B., Wang, W., Xie, Y., & Zheng, J. (2022) · Respiratory Research · doi:10.1186/s12931-021-01920-8 · Cited by 60
Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract
Pivard, M., Moreau, K., & Vandenesch, F. (2021) · mSphere · doi:10.1128/msphere.00059-21 · Cited by 69
“monary mucus (17, 50) that is composed of mucin (51) and surfactant proteins (18, 52).”
BackgroundMucin networks: Dynamic structural assemblies controlling mucus function
Fass, D., & Thornton, D. J. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102524 · Cited by 59
Self-citationThe bacterial microbiota in inflammatory lung diseases
Huffnagle, G. B., & Dickson, R. P. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.022 · Cited by 61
Kerr, S. C., Fischer, G. J., Sinha, M., McCabe, O., Palmer, J. M., Choera, T., Yun Lim, F., Wimmerova, M., Carrington, S. D., Yuan, S., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005555 · Cited by 53
The Epithelial-Immune Crosstalk in Pulmonary Fibrosis
Planté-Bordeneuve, T., Pilette, C., & Froidure, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631235 · Cited by 67
“In vivo data indicates a crucial role for MUC5B in the maintenance of healthy interactions between the host and bacteria, as Muc5b but not Muc5ac animals display impaired survival related to respiratory infections (40).”
BackgroundMucus, Microbiomes and Pulmonary Disease
Meldrum, O. W., & Chotirmall, S. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060675 · Cited by 58
“While conceptually plausible, simply reducing mucus secretion alone appears relevant, but may not be wholly effective due to the adverse consequences of inadvertently eliminating MUC5B, which in mouse models has shown to promote mucus accumulation and chronic infection [38].”
BackgroundTirelli, C., Pesenti, C., Miozzo, M. R., Mondoni, M., Fontana, L., & Centanni, S. (2022) · Diagnostics · doi:10.3390/diagnostics12123107 · Cited by 58
“Genetic variants of MUC5B, causing its overexpression in the bronchoalveolar epithelium, are recognized as one of the main risk factors for IPF, although the specific mechanism, which is involved in the induction of IPF is not already clear [52].”
BackgroundThe innate immune architecture of lung tumors and its implication in disease progression
Milette, S., Fiset, P., Walsh, L. A., Spicer, J. D., & Quail, D. F. (2019) · The Journal of Pathology · doi:10.1002/path.5241 · Cited by 58
“Upon degranulation, these enzymes stimulate mucus production [43,44], and cleave cytokine pro-peptides to amplify immune responses [45].”
BackgroundWhat have we learned from basic science studies on idiopathic pulmonary fibrosis?
Yanagihara, T., Sato, S., Upagupta, C., & Kolb, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0029-2019 · Cited by 53
Targeting Mucus Hypersecretion: New Therapeutic Opportunities for COPD?
Martin, C., Frija‐Masson, J., & Burgel, P. (2014) · Drugs · doi:10.1007/s40265-014-0235-3 · Cited by 59
The respiratory microbiome and innate immunity in asthma
Huang, Y. J. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000124 · Cited by 54
Secreted mucins and airway bacterial colonization in non‐ CF bronchiectasis
Sibila, O., Suárez-Cuartín, G., Rodrigo‐Troyano, A., Fardon, T. C., Finch, S., Mateus, E. F., Garcia‐Bellmunt, L., Castillo, D., Vidal, S., Sánchez, F., et al. (2015) · Respirology · doi:10.1111/resp.12595 · Cited by 54
Borie, R., Kannengiesser, C., Nathan, N., Tabèze, L., Pradère, P., & Crestani, B. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.07.017 · Cited by 59
Manni, M. L., Mandalapu, S., McHugh, K. J., Elloso, M. M., Dudas, P. L., & Alcorn, J. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501531 · Cited by 54
Xu, T., Ge, X., Lu, C., Dai, W., Chen, H., Xiao, Z., Wu, L., Liang, G., Ying, S., Zhang, Y., et al. (2019) · Aging · doi:10.18632/aging.102371 · Cited by 54
“However, in recent years, MUC5B has been shown to have physiologic functions in the mucus that ensure its normal clearance, and the levels of MUC5B in asthma remain stable or even decrease in some cases [55].”
BackgroundMechanistic Insights into the Impact of Air Pollution on Pneumococcal Pathogenesis and Transmission
Beentjes, D., Shears, R. K., French, N., Neill, D. R., & Kadioglu, A. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2668tr · Cited by 55
Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems
Hamza, F. N., Daher, S., Fakhoury, H. M. A., Grant, W. B., Kvietys, P. R., & AlKattan, K. M. (2023) · Nutrients · doi:10.3390/nu15071696 · Cited by 234
“MCC is decreased in MUC5B−/− mice, but not in MUC5AC−/− mice and the MUC5B−/− mice are more susceptible to bacterial infection [156].”
BackgroundPlatelets favor the outgrowth of established metastases
García-León, M. J., Liboni, C., Mittelheisser, V., Bochler, L., Follain, G., Mouriaux, C., Busnelli, I., Larnicol, A., Colin, F., Peralta, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47516-w · Cited by 58
“Expression of Nos1 and Muc5b underlined by tissue-wide RNASeq suggested that recruited IM possessed a pro-in fl ammatory phenotype 43,44 .”
BackgroundSala‐Rabanal, M., Yurtsever, Z., Berry, K. N., & Brett, T. J. (2015) · Mediators of Inflammation · doi:10.1155/2015/497387 · Cited by 49
Nakamura, S., Horie, M., Daidoji, T., Honda, T., Yasugi, M., Kuno, A., Komori, T., Okuzaki, D., Narimatsu, H., Nakaya, T., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02246-15 · Cited by 54
Mucus strands from submucosal glands initiate mucociliary transport of large particles
Fischer, A. J., Pino-Argumedo, M. I., Hilkin, B. M., Shanrock, C. R., Gansemer, N. D., Chaly, A. L., Zarei, K., Allen, P. D., Ostedgaard, L. S., Hoffman, E. A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124863 · Cited by 49
Xie, T., Luo, G., Zhang, Y., Wang, X., Wang, X., Wu, M., & Li, G. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12606 · Cited by 48
Biondini, D., Cocconcelli, E., Bernardinello, N., Lorenzoni, G., Rigobello, C., Lococo, S., Castelli, G., Baraldo, S., Cosio, M. G., Gregori, D., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01694-z · Cited by 48
“MUC5B encodes a mucin 5B precursor protein that contributes to airway mucus production and homeostasis [9].”
BackgroundKim, M. D., Chung, S., Baumlin, N., Qian, J., Montgomery, R. N., Sabater, J. R., Berkland, C. J., & Salathe, M. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-52317-8 · Cited by 58
“MUC5B is the other major gel-forming mucin expressed in the airway epithelium that is required for proper mucociliary clearance 32 .”
BackgroundVal, S., Poley, M., Brown, K. J., Choi, R., Jeong, S., Colberg-Poley, A., Rose, M. C., Panchapakesan, K., Devaney, J. C., Pérez‐Losada, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152865 · Cited by 53
Zhao, R., Guo, Z., Dong, W., Deng, C., Han, Z., Liu, J., Wang, H., Zhuang, G., & Zhang, R. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22182 · Cited by 47
Gellatly, S. L., Pavelka, N., Crue, T., Schweitzer, K. S., Day, B. J., Min, E., Numata, M., Voelker, D. R., Scruggs, A. K., Petrache, I., et al. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s244434 · Cited by 50
Toll interacting protein protects bronchial epithelial cells from bleomycin‐induced apoptosis
Li, X., Kim, S. E., Chen, T., Wang, J., Yang, X., Tabib, T., Tan, J., Guo, B., Fung, S., Zhao, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902636rr · Cited by 46
Claudin-1 Mediated Tight Junction Dysfunction as a Contributor to Atopic March
Xia, Y., Cao, H., Zheng, J., & Chen, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927465 · Cited by 54
Zanin, M., Marathe, B. M., Wong, S., Yoon, S., Collin, E. A., Oshansky, C. M., Jones, J. C., Hause, B. M., & Webby, R. J. (2015) · Journal of Virology · doi:10.1128/jvi.02537-14 · Cited by 58
“Further, mice that do not express MUC5B, the other major secreted respiratory mucin, showed severely impaired mucociliary clearance and perturbed immune responses and succumbed to bacterial lung infections (33).”
BackgroundProgress in understanding mucus abnormalities in cystic fibrosis airways
Wine, J. J., Hansson, G. C., König, P., Joo, N. S., Ermund, A., & Pieper, M. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.09.003 · Cited by 53
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Amati, F., Stainer, A., Mantero, M., Gramegna, A., Simonetta, E., Suigo, G., Voza, A., Nambiar, A. M., Cariboni, U., Oldham, J. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020977 · Cited by 49
“Some genetic variants commonly associated with IPF, such as the mutant T allele of the MUC5B rs35705950 polymorphism, can facilitate infections and dysbiosis through alterations in the innate immune defense and perpetuate the wound-healing mechanism [5,39].”
Background
Metadata
- Authors
- Roy, M. G., Livraghi-Butrico, A., Fletcher, A. A., McElwee, M. M., Evans, S. E., Boerner, R. M., Alexander, S. N., Bellinghausen, L. K., Song, A. S., Petrova, Y. M., Tuvim, M. J., Adachi, R., Romo, I., Bordt, A. S., Bowden, M. G., Sisson, J. H., Woodruff, P. G., Thornton, D. J., Rousseau, K., De la Garza, M. M., Moghaddam, S. J., Karmouty-Quintana, H., Blackburn, M. R., Drouin, S. M., Davis, C. W., Terrell, K. A., Grubb, B. R., O’Neal, W. K., Flores, S. C., Cota-Gomez, A., Lozupone, C. A., Donnelly, J. M., Watson, A. M., Hennessy, C. E., Keith, R. C., Yang, I. V., Barthel, L., Henson, P. M., Janssen, W. J., Schwartz, D. A., Boucher, R. C., Dickey, B. F., & Evans, C. M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of North Carolina at Chapel Hill (US)
- University of Colorado Anschutz (US)
- The University of Texas Health Science Center at Houston (US)
- Texas A&M Health Science Center (US)
- Nebraska Medical Center (US)
- University of California, San Francisco (US)
- University of Manchester (GB)
- National Jewish Health (US)
- Corresponding author
- Evans, Christopher M.
- ORCID
- Livraghi-Butrico, Alessandra
- Fletcher, Ashley A.
- Evans, Scott E.
- Tuvim, Michael J.
- Adachi, Roberto
- Bordt, Andrea S.
- Bowden, M. Gabriela
- Sisson, Joseph H.
- Woodruff, Prescott G.
- Thornton, David J.
- Moghaddam, Seyed J.
- Blackburn, Michael R.
- Grubb, Barbara R.
- O’Neal, Wanda K.
- Lozupone, Catherine A.
- Watson, Alan M.
- Hennessy, Corinne E.
- Keith, Rebecca C.
- Yang, Ivana V.
- Barthel, Lea
- Henson, Peter M.
- Janssen, William J.
- Schwartz, David A.
- Boucher, Richard C.
- Dickey, Burton F.
- Evans, Christopher M.
- Venue
- Nature
- Published
- 2013-12-08
- Volume
- 505
- Issue
- 7483
- Pages
- 412-416
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4001806
- OpenAlex
- W2008440267
- Cited by
- 764
- References
- 54
- Citations by year
- 2026: 42 · 2025: 41 · 2024: 70 · 2023: 61 · 2022: 76 · 2021: 76 · 2020: 78 · 2019: 58 · 2018: 78 · 2017: 52 · 2016: 53 · 2015: 48 · 2014: 28 · 2013: 2
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA008769)
- National Heart, Lung, and Blood Institute (R01HL097163, R01HL097591, R01HL097000, P01HL110873, P01HL107202, R33HL120770, DP2HL123229, R01HL095372, P50HL107168, P01HL108808, R01HL109517, R01HL117976, R01HL114381, R01HL080396)
- National Cancer Institute (CA 046934, CA 016672, CA016086, P30CA016672, P30CA046934, P30CA016086)
- National Institute of Allergy and Infectious Diseases (U19AI077439)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK090285, P30DK065988)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- MUC5AC, airway mucin, mucociliary clearance, bacterial infection, otitis media, macrophage phagocytosis, IL-23, allergic asthma, chronic obstructive pulmonary disease, Staphylococcus aureus, mucus hypersecretion
- MeSH terms
- Animals, Asthma, Bacterial Infections, Cilia, Ear, Middle, Female, Inflammation, Lung, Macrophages, Male, Mice, Inbred C57BL, Mice, Transgenic, Models, Biological, Phagocytosis, Staphylococcus aureus, Survival Analysis, Respiratory Mucosa, Pulmonary Disease, Chronic Obstructive, Mice, Mucin-5B, Mucin 5AC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.